Table: Oncolys Biopharma - 9-MTH parent results
Nov 5 (Reuters)-
Oncolys Biopharma Inc.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Sep 30, 2021 Sep 30, 2020 Dec 31, 2021
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 318 mln 207 mln
(+53.3 pct) (-67.5 pct)
Operating loss 963 mln loss 1.17
Recurring loss 976 mln loss 1.19
Net loss 979 mln loss 1.55
EPS loss 58.42 yen loss 107.64 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Oncolys Biopharma Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T